Frost & Sullivan Presents the Unprecedented Opportunities in the Personal Protection Equipment Industry

The COVID-19 pandemic has caught the world by surprise, and a shortage of personal protective equipment (PPE) has exposed the vulnerability of our healthcare and emergency response systems. While the virus has uncovered industry shortcomings, such as its dependence on outsourced supply chains, demand for PPE is thriving and creating market opportunities globally.

According to Frost & Sullivan, on average, the industry grows at 3% to 5% per annum; however, the healthcare PPE segment is now experiencing an unprecedented boom, estimated at 80% to 100%, and is opening doors for new entrants, alliances, and partnership opportunities between PPE players and material suppliers.

Frost & Sullivan invites you to join Global President & Managing Partner Aroop Zutshi and Vice President Sanjiv Bhaskar for the Growth Opportunity briefing, “COVID-19: Growth Opportunities in the PPE Industry,” on May 7 at 11 a.m. EST.

Frost & Sullivan notes the briefing will highlight how the PPE industry can seize the growth opportunities presented and remain a favorite of the private equity community, and also discuss how the pandemic will change the PPE industry’s approach to different end-user industries.

For more information and to register for the webinar, please visit: http://frost.ly/42t

Key benefits of attending this webinar:

  • Understand the impact of COVID-19 on the industrial PPE markets.
  • Identify global opportunities for industrial PPE supplies of masks, gowns and eye protection in the healthcare industry.
  • Expose potential new competitors to industrial PPE players.
  • Discover how to overcome supply chain challenges such as over-dependence on imports.
  • Capitalize on the growing userbase to help your company expand.
  • Find out if COVID-19 will reverse the PPE consolidation trend or enhance it.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version